Methyl conjugation is an important pathway in the metabolism of drugs, xenobiotics, endogenous compounds and neurotransmitters. The experiments proposed are designed to enhance our understanding of the biological basis for individual variations in methyl conjugation. Our laboratory has already discovered genetic polymorphisms that regulate activities of the O-methylating enzyme, catechol-O-methyltransferase (COMT) and the S-methylating enzyme, thiopurine methyltransferase (TPMT) in man. We propose to expand our studies of TPMT to include experiments with inbred strains of mice with very different TPMT activities and experiments with cultured human lymphocytes from subjects with different TPMT genotypes. In addition, our studies of methyl conjugation will be extended to include the enzyme histamine N-methyltransferase (HNMT). We have recently confurmed that HNMT activity is present in an easily accessible human tissue, the erythrocyte (RBC). We have developed a sensitive assay for the measurement of RBC HNMT activity. One goal of this proposal is to determine whether variations in the biochemical properties and regulation of HNMT in the human RBC are influenced by inheritance. It will then be determined whether the biochemical properties and regulation of HNMT in an easily accessible tissue, the RBC, are similar to and are correlated with those of HNMT in the kidney and liver, two less accessible human tissues. To accomplish these goals, HNMT activity will be measured in RBCs of first-degree ralatives, and the role of inheritance in regulating variations in the level of activity will be determined. HNMT will be purified from the human RBC, human kidney and human liver, and the biochemical properties of the enzyme in those tissues will be compared. Individual variation in RBC HNMT activities will be correlated with variations in HNMT activities in samples of human kidney and liver obtained during clinically-indicated nephrectomies and partial hepatectomies. Monoclonal and polyclonal antibodies to human HNMT will be developed to study the cellular localization of the enzyme in human organs and to study mechanisms responsible for individual variations in the level of activity of the enzyme. The results of these experiments will enhance our understanding of the biological basis for individual variations in the activities of enzymes that catalyze the S-and N-methylation of drugs, xenobiotics, and endogenous compounds.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM028157-10
Application #
3275438
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1980-07-01
Project End
1990-11-30
Budget Start
1989-07-01
Budget End
1990-11-30
Support Year
10
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Qin, Sisi; Liu, Duan; Kohli, Manish et al. (2018) TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer. Clin Pharmacol Ther 104:201-210
Liu, Duan; Qin, Sisi; Ray, Bamiki et al. (2018) Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction. Drug Metab Dispos 46:1372-1381
Gonzalez-Mercado, Velda J; Fridley, Brooke L; Saligan, Leorey N (2018) Sestrin family of genes and their role in cancer-related fatigue. Support Care Cancer 26:2071-2074
Wang, Liewei; Ingle, James; Weinshilboum, Richard (2018) Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study. Clin Pharmacol Ther 103:243-252
Athreya, Arjun P; Gaglio, Alan J; Cairns, Junmei et al. (2018) Machine Learning Helps Identify New Drug Mechanisms in Triple-Negative Breast Cancer. IEEE Trans Nanobioscience 17:251-259
Ho, Ming-Fen; Lummertz da Rocha, Edroaldo; Zhang, Cheng et al. (2018) TCL1A, a Novel Transcription Factor and a Coregulator of Nuclear Factor ?B p65: Single Nucleotide Polymorphism and Estrogen Dependence. J Pharmacol Exp Ther 365:700-710
Liu, Duan; Ray, Balmiki; Neavin, Drew R et al. (2018) Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Transl Psychiatry 8:10
Athreya, Arjun; Iyer, Ravishankar; Neavin, Drew et al. (2018) Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive Disorder. IEEE Comput Intell Mag 13:20-31
Yu, Jia; Qin, Bo; Moyer, Ann M et al. (2018) DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest 128:2376-2388
Ho, Ming-Fen; Correia, Cristina; Ingle, James N et al. (2018) Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression. Biochem Pharmacol 152:279-292

Showing the most recent 10 out of 246 publications